stigmasterol and Keratitis--Herpetic

stigmasterol has been researched along with Keratitis--Herpetic* in 3 studies

Other Studies

3 other study(ies) available for stigmasterol and Keratitis--Herpetic

ArticleYear
Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis: Antiangiogenic stigmasterol derivatives.
    Steroids, 2016, Volume: 115

    Angiogenesis plays a critical role in initiating and promoting several diseases, such as cancer and herpetic stromal keratitis (HSK). Herein, we studied the inhibitory effect of two synthetic stigmasterol derivatives on capillary tube-like structures and on cell migration in human umbilical vein endothelial cells (HUVEC): (22S,23S)-22,23-dihydroxystigmast-4-en-3-one (compound 1) and (22S,23S)-3β-bromo-5α,22,23-trihydroxystigmastan-6-one (compound 2). We also studied their effect on VEGF expression in IL-6 stimulated macrophages and in LMM3 breast cancer cells. Furthermore, we investigated the antiangiogenic activity of the compounds on corneal neovascularization in the murine model of HSK and in an experimental model of tumor-induced angiogenesis in mice. Both compounds inhibited capillary tube-like formation, but only compound 1 restrained cell migration. Compound 1, unlike compound 2, was able to reduce VEGF expression. Only compound 1 not only reduced the incidence and severity of corneal neovascularization, when administered at the onset of HSK, but it also restrained the development of neovascular response induced by tumor cells in mice skin. Our results show that compound 1 inhibits angiogenesis in vitro and in vivo. Therefore, compound 1 would be a promising drug in the treatment of those diseases where angiogenesis represents one of the main pathogenic events.

    Topics: Animals; Blotting, Western; Cell Line; Cell Survival; Corneal Neovascularization; Human Umbilical Vein Endothelial Cells; Humans; Keratitis, Herpetic; Male; Mice; Mice, Inbred BALB C; Stigmasterol

2016
Immunomodulatory activity of an anti-HSV-1 synthetic stigmastane analog.
    Bioorganic & medicinal chemistry, 2013, Jan-15, Volume: 21, Issue:2

    Many viral infections are associated with the development of immunopathologies and autoimmune diseases, which are of difficult treatment and for which no vaccines are yet available. Obtaining compounds that conjugate both antiviral and immunomodulatory activities in the same molecule would be very useful for the prevention and/or treatment of these immunopathologies. The compound (22S,23S)-22,23-dihydroxystigmast-4-en-3-one (compound 1) displays anti-Herpes simplex virus type 1 activity in vitro and reduces the incidence of herpetic stromal keratitis (HSK) in mice, a chronic inflammatory syndrome induced by ocular HSV-1 infection. In the present study, compound 1 showed opposite immunomodulatory properties in vitro. It induced the release of pro-inflammatory cytokines in HSV-1-infected epithelial cells of ocular origin, and significantly reduced the production of these cytokines in LPS-activated macrophages. RNA microarrays revealed various overexpressed and repressed genes in compound 1 treated infected epithelial cells and activated macrophages, many of which are associated with innate immune responses and inflammatory processes. These immunomodulatory properties of compound 1, together with its previously reported antiviral activity, make it a potential drug for the treatment of HSK and many other immunopathologies of viral and non-viral origin.

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cholestenones; Corneal Stroma; Cytokines; Epithelial Cells; Gene Expression Profiling; Herpesvirus 1, Human; Humans; Immunologic Factors; Keratitis, Herpetic; Mice; NF-kappa B; Stigmasterol; Transcriptional Activation

2013
Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives.
    The Journal of steroid biochemistry and molecular biology, 2008, Volume: 111, Issue:1-2

    Stromal keratitis resulting from ocular infection with Herpes simplex virus type 1 (HSV-1) is a common cause of blindness. This report investigates the antiviral and anti-inflammatory properties of two new synthetic stigmastane analogs in the experimental model of HSV-1-induced ocular disease in mice. (22S,23S)-22,23-dihydroxystigmast-4-en-3-one (1) and (22S,23S)-22,23-dihydroxystigmasta-1,4-dien-3-one (2) exhibited anti-HSV-1 activity in vitro and ameliorated the signs of murine herpetic stromal keratitis (HSK), although none of the compounds showed antiviral activity in vivo. We discuss that the improvement of HSK could be due to an immunomodulatory effect of both compounds.

    Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; beta-Galactosidase; Cell Line; Cell Survival; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium, Corneal; Formazans; Herpesvirus 1, Human; Humans; Inhibitory Concentration 50; Keratitis, Herpetic; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Spectrophotometry; Stigmasterol; Tetrazolium Salts; Time Factors; Vero Cells

2008